Reporting by Asif Shahzad; Editing by John Stonestreet and Alex RichardsonOur Standards: The Thomson Reuters Trust Principles. Reporting by Asif Shahzad Editing by Raissa KasolowskyOur Standards: The Thomson Reuters Trust Principles. "We've acquired technology and expertise to ensure quality control," he said. China's Sinopharm, AstraZeneca and Russia's Sputnik V have also received authorisation. Picture taken June 3, 2021.
This is an honoured blog.
( z0 blog :ARG1-of ( z1 honor ) :domain ( z2 this ) )
(z0 / blog
    :ARG1-of (z1 / honor-01)
    :domain (z2 / this))
This is an honoured blog .
z0 :ARG1-of z1
z0 :domain z2